Olopatadine Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Eczema Eyelids 50.0%
Keratitis 50.0%
Visual Acuity Reduced 100.0%
Secondary
Product Used For Unknown Indication 43.2%
Drug Exposure In Utero 10.6%
Foetal Exposure During Pregnancy 10.6%
Sciatic Nerve Injury 3.8%
Gastritis 3.0%
Inflammation 3.0%
Migraine 3.0%
Rheumatoid Arthritis 3.0%
Age-related Macular Degeneration 2.3%
Neurosis 2.3%
Angina Pectoris 1.5%
Atopy 1.5%
Bronchitis 1.5%
Constipation 1.5%
Dyspepsia 1.5%
Eczema 1.5%
Eczema Eyelids 1.5%
Escherichia Infection 1.5%
Hypertension 1.5%
Intervertebral Disc Protrusion 1.5%
Torticollis 19.0%
Hepatic Function Abnormal 9.5%
Altered State Of Consciousness 4.8%
Aphasia 4.8%
Bronchial Hyperreactivity 4.8%
C-reactive Protein Increased 4.8%
Caesarean Section 4.8%
Drug-induced Liver Injury 4.8%
Granuloma 4.8%
Jaundice 4.8%
Photophobia 4.8%
Rash 4.8%
Stevens-johnson Syndrome 4.8%
Tremor 4.8%
Urosepsis 4.8%
Urticaria 4.8%
Visual Acuity Reduced 4.8%
Concomitant
Product Used For Unknown Indication 26.1%
Psoriasis 14.5%
Rheumatoid Arthritis 12.3%
Drug Use For Unknown Indication 5.1%
Hypertension 4.0%
Rash 3.9%
Insomnia 3.4%
Hiv Infection 3.1%
Psoriatic Arthropathy 3.1%
Gastritis Prophylaxis 2.6%
Hypersensitivity 2.6%
Pruritus 2.5%
Multiple Allergies 2.4%
Diabetes Mellitus 2.3%
Constipation 2.2%
Osteoporosis 2.2%
Prophylaxis 2.2%
Gastritis 1.9%
Asthma 1.8%
Depression 1.7%
Tubulointerstitial Nephritis 12.7%
Dermal Cyst 7.8%
Pneumonia 7.8%
Pyelonephritis Acute 6.9%
Mycobacterium Tuberculosis Complex Test Positive 5.9%
White Blood Cell Count Decreased 5.9%
Cerebral Infarction 4.9%
Myocardial Infarction 4.9%
Rhabdomyolysis 4.9%
Drug Ineffective 3.9%
Lung Neoplasm Malignant 3.9%
Rash 3.9%
Rash Generalised 3.9%
Stomatitis 3.9%
Suicidal Ideation 3.9%
Herpes Zoster 2.9%
Malaise 2.9%
Meningitis Cryptococcal 2.9%
Ocular Hyperaemia 2.9%
Pain 2.9%